Valve-in-valve transcatheter mitral valve replacement (ViV TMVR) may provide value as an effective alternative to redo surgical mitral valve replacement (SMVR) in patients with mitral prosthesis dysfunction, according to new findings published in the Journal of the American Heart Association.